Profile
IMM Investment, Corp. is a leading multi-asset alternative investment firm based in Seoul, Korea. Established in September 1999, the firm focuses on venture capital, growth equity, and infrastructure investments. IMM prides itself on its large and diverse team of over 70 investment professionals spread across offices in Seoul, Tokyo, and Hong Kong. This experienced team collaborates to generate top risk-adjusted returns across various market environments. The firm's ability to operate across different geographies and stages makes it stand out among its peers.
Their investment approach covers multiple stages and sectors, including information technology, healthcare/biotech, and manufacturing, with a notable focus on innovative entrepreneurs. IMM Investment typically makes investments of $10-50 million, with their current total assets under management being approximately USD 7.7 billion. They are known for their diverse asset strategy, which includes growth equity, infrastructure investments, venture capital, real estate, and fund-of-funds.
Notable portfolio companies include Celltrion - a biosimilar company, Novelis Korea - specializing in manufacturing flat-rolled aluminum products, Hanjin Newport, PSA Hyundai Pusan Newport Terminal, Hyundai LNG Shipping, and Incheon Total Energy Company. These diverse investments demonstrate IMM's capability to execute strategic investments both domestically and internationally.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.